Biotech Caladrius Biosciences Announces Orphan Drug Designation for CLBS12 for the Treatment of Buerger’s Disease March 8, 2021
Biotech Cleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China Region March 8, 2021
Biotech Heat Biologics to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 8, 2021
Biotech Aridis Enters into APEX(TM) Licensing and Product Discovery Agreement for Zoonotic Viruses with Kermode March 8, 2021
Biotech Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma March 8, 2021
Biotech ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – AQST March 6, 2021
Biotech SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Five Prime Therapeutics, Inc. – FPRX March 5, 2021
Biotech SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Five Prime Therapeutics, Inc. (Nasdaq – FPRX) March 5, 2021